2,2,4-Trimethylpentane

CASRN 540-84-1

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (12 pp, 170 K) last updated: 07/31/2007
Information reviewed but value not estimated.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (12 pp, 170 K) last updated: 07/31/2007
Information reviewed but value not estimated.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (12 pp, 170 K) last updated: 07/31/2007

WOE Characterization Framework for WOE Characterization
Inadequate information to assess carcinogenic potential (Oral route) Guidelines for Carcinogen Risk Assessment (US EPA, 2005)
Basis:
  • In accordance with the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005a), there is inadequate information to assess carcinogenic potential for 2,2,4-trimethylpentane.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (12 pp, 170 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (12 pp, 170 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.